Infection Surveillance Solutions Market PPT 2023: Size, Growth, Demand and Forecast Till 2028

Author: Elena Anderson Marketing Manager

Report DescriptionAbout IMARC Group

International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description Report Description and Highlights

Global Infection Surveillance Solutions Market Research Report 2023-2028:

According to the latest report by IMARC Group, titled " InfectionSurveillanceSolutionsMarket:GlobalIndustryTrends,Share,Size,Growth,Opportunitya ndForecast2023-2028

," the global infection surveillance solutions market size reached US$ 580.9 Million in 2022.

Infection surveillance solutions are generally utilized by healthcare professionals for the systematic collection and interpretation of health-related data. They assist in evaluating and monitoring the epidemiology of health problems, planning public health policies and strategies, and guiding priority settings.

Additionally, they are also used for determining infection trends and shifts in microbial pathogens while providing healthcare institutions with accurate data on patient and employee surgical and health databases with real-time monitoring. Due to rapid digitization across the healthcare sector, there has been a considerable rise in the adoption of infection surveillance solutions across the globe. Request for a PDF sample of this report: https://www.imarcgroup.com/infection-surveillance-solutions-market/requestsample

Global Infection Surveillance Solutions Market Trends:

The global market is primarily driven by the increasing prevalence of virus-acquired infections. This is supported by the escalating need for continuous monitoring and interpretation of health-related data for the accurate implementation of preventive solutions in order to control the spread of diseases. Coupled with the rapid outbreak of the coronavirus disease (COVID-19), this has further propelled the market growth. Moreover, numerous initiatives undertaken by the government of multiple countries in order to improve the quality of patient care and safety are providing a boost to the demand for infection surveillance systems across the globe. In line with this, the rising investments and funding activities by private and public agencies for the deployment of advanced infection surveillance are creating a positive market outlook. Other factors, including continuous improvements in the healthcare and information technology (IT) infrastructures, the growing preference for cloud-based software, and extensive research and development activities (R&D) conducted by key players, are also positively influencing the market. Looking forward, IMARC Group expects the market to reach a value of US$ 1,177.7 Million by 2028, exhibitingataCAGRof12.1%during2023-2028.

View Report TOC, Figures and Tables:

https://www.imarcgroup.com/infection-surveillance-solutions-market

Report Description Report Description and Highlights

Key Market Segmentation

The research report includes the following segments:

Breakup by Component:

• Software

• Services

Breakup by Deployment Type:

• On-premises

• Cloud-based

Breakup by End User:

• Hospitals

• Clinics

• Ambulatory Service Centers

• Specialty Centers

• Others

Report Description Report Description and Highlights

Breakup by Region:

• North America

• Asia Pacific

• Europe

• Latin America

• Middle East and Africa

Competitive Landscape with Key Players:

• Baxter International Inc

• Becton Dickinson and Company

• Centrak Inc. (Halma plc)

• Cerner Corporation

• CKM Healthcare Incorporated

• Ecolab Inc

• International Business Machines Corporation

• Medexter Healthcare

• Perahealth Inc

• PointClickCare

• Premier Inc

• Sunquest Information Systems Inc. (Roper Technologies Inc.)

1. Whatwasthesizeoftheglobalinfectionsurveillancesolutionsmarketin2022?

2. What is the expected growth rate of the global infection surveillance solutions market during 2023-2028?

3. Whatarethekeyfactorsdrivingtheglobalinfectionsurveillancesolutionsmarket?

4. WhathasbeentheimpactofCOVID-19ontheglobalinfectionsurveillancesolutionsmarket?

5. What is the breakup of the global infection surveillance solutions market based on the component?

6. What is the breakup of the global infection surveillance solutions market based on the deploymenttype?

7. Whatisthebreakupoftheglobalinfectionsurveillancesolutionsmarketbasedontheenduser?

8. Whatarethekeyregionsintheglobalinfectionsurveillancesolutionsmarket?

9. Whoarethekeyplayers/companiesintheglobalinfectionsurveillancesolutionsmarket?

Clickheretovisitthecompletetableofcontentwithlistoffiguresandtables

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

Report Description Report Description and Highlights

© 2022 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.